Immatics
unique capability identification of the most relevant target | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
62 of 75
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical target evaluation of sensitization and resistance markers from public pooled screens in the recursion map identification of an unexpected gene similar to identification of novel dual targeting modifier monitor local immune engagement show immune based clearance and associated new target identified for annotated gene a inhibitor measure peripheral inflammation show reduced inflammatory risk potential first in class with enhance anti response | Recursion Pharmaceuticals
Melrose
Investor Presentation
May 2023
accelerating the scale up of disruptive additive capability | Melrose
BenevolentAI
Investor Conference
January 2023
the benevolent platform comprehensive data foundations biology hypothesis driven data foundations target identification | BenevolentAI
Kymera
Investor Day
December 2021
novel to drug a new generation of targets | Kymera
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io